J. Mark FitzGerald

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis”.

Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00124-7

N/A

4.3DataRank · unranked

143 citations

Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald, Megan S. Rice, Nadia Daizadeh +8 more

Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.06.036

N/A

1.2DataRank · unranked

24 citations

J. Mark FitzGerald, Eric D. Bateman, Mario Castro, Ian Pavord, Jorge Máspero +8 more

Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma

European Respiratory Journal(2021)10.1183/13993003.00413-2021

N/A

0DataRank · unranked

72 citations

Guy Brusselle, J. Mark FitzGerald, Ian Pavord, M. Keith, Malin Fagerås +5 more

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.10.059

N/A

0DataRank · unranked

62 citations

Elisabeth H. Bel, Arnaud Bourdin, Ignacio Dávila, John Aubrey Douglass, J. Mark FitzGerald +7 more

Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

Annals of Allergy Asthma & Immunology(2022)10.1016/j.anai.2022.10.018

N/A

0DataRank · unranked

16 citations

Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald +15 more